Skip to main content
Tessa NewsLink
Paste a health news link, or browse
Latest checks

Welcome to the Tessa News Link Beta! We are actively improving this experience.

Share Feedback

Several possible studies

Story checked

Two compounds target drug-resistant brain cancer cells in laboratory tests (opens in a new tab)

medicalxpress.com · 2026-11-06

Short answerEvidenceSource

Short answer

Several possible studies

Study not confirmed.

Several potential source studies were identified, but no single match could be confirmed. The article's claims remain unverified.

17 candidate papersExplore the search results

These papers were considered as possible sources, but none could be confirmed as the study behind this story.

Share this check

Help improve NewsLink

Tell us what worked or what needs attention in this check.

Follow the evidence trail
1
2

NewsLink checks it

Multiple potential source studies identified.

Several studies match details in the article, but none could be confirmed as its source. The claims have not been assessed against a source study.

View article claims
3

Search result

Several studies could fit.

Several studies match details in the article, but none could be confirmed as its source. The claims have not been assessed against a source study.

Source paper

Source layer

The 3 papers the story cites

Source study separated from background citations.

The research anchor for the report.

The literature search

17 candidate papers

Studies identified during the search

These papers appeared in the search for the story’s source. None was confirmed as a direct match. Inclusion here does not mean a paper supports or contradicts the story, or that its full text was reviewed.

Show 13 more search results
Then inspect each claim

Evidence layer

Claim by claim

The article's claims are listed below. Without a confirmed source study, they have not been assessed as supported or unsupported.

Claim 1 of 5Not checkedResearch from the Indian Institute of Technology Gandhinagar explores two compounds that may help tackle drug-resistant glioblastoma by targeting the TTK/Mps1 protein, and the results were published in the Journal of Biological Chemistry and RSC Medicinal Chemistry.View evidenceHide evidence

Not checked

No source study was confirmed for this article. This claim remains unverified, rather than assessed as supported or unsupported.

Claim 2 of 5Not checkedLaboratory experiments found that SPK17 (G17) stood out among more than 10 compounds and had an IC50 about 176 times lower than temozolomide in LN229 cells and 85 times lower in U87MG cells; it also produced about eight times the cell-death signal at 10 micromolar versus 200 micromolar temozolomide in TMZ-resistant LN229-TMZ-R cells.View evidenceHide evidence

As statedapproximately 176 times lower; approximately 85 times lower; approximately eight times the cell-death signal

Not checked

No source study was confirmed for this article. This claim remains unverified, rather than assessed as supported or unsupported.

Claim 3 of 5Not checkedSPK17b (G17b) was the most prominent among five compounds in the other study, with IC50 values about 81 times lower than temozolomide in LN229 cells and 59 times lower in U87MG cells, and it also showed a lower concentration needed to produce a cell-death signal in TMZ-resistant LN229-TMZ-R cells.View evidenceHide evidence

As statedapproximately 81 times lower; approximately 59 times lower

Not checked

No source study was confirmed for this article. This claim remains unverified, rather than assessed as supported or unsupported.

Claim 4 of 5Not checkedThe article says SPK17b also impaired the cells’ ability to metastasize or spread, and the authors suggest the compounds may interfere with several processes that help tumor cells survive and multiply.View evidenceHide evidence

Not checked

No source study was confirmed for this article. This claim remains unverified, rather than assessed as supported or unsupported.

Claim 5 of 5Not checkedThe researchers say future work will test the compounds in animal studies and assess whether the benefits outweigh the risks.View evidenceHide evidence

Not checked

No source study was confirmed for this article. This claim remains unverified, rather than assessed as supported or unsupported.

Finally, the search trail

Method layer

Study not confirmed.

The search results are available for you to inspect. Without a confirmed source study, they cannot establish whether the story’s claims are supported or contradicted.

Search results

Candidate papers, not confirmed sources.

Europe PMC, Crossref, PubMed · 15 candidate papers

Candidate

Multidimensional hydrogel models reveal endothelial network angiocrine signals increase glioblastoma proliferation, invasion, and temozolomide resistance

Crossref

Source (opens in a new tab)

Explore all search results